## Abstract To a limited extent, thrombotic thrombocytopenic purpura (TTP) in addition to its clinical features is being defined nowadays with laboratory tests such as the assay for the Von Willebrand factor‐cleaving protease (ADAMTS 13) and its antibody. We present a case report of a patient with
Long-term remission in a patient with refractory thrombotic thrombocytopenic purpura treated with rituximab and plasma exchange
✍ Scribed by A. L. Basquiera; J. C. Damonte; P. Abichaín; A. G. Sturich; J. J. García
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 84 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Some patients with thrombotic thrombocytopenic purpura (TTP) remain plasmaexchange-dependent for prolonged periods of time. This exposes patients to risk, uses substantial resources, and requires prolonged hospitalization. We have splenectomized 7 such patients following 25-42 plasma exchanges while
## Abstract The association of ulcerative colitis (UC) and thrombotic thrombocytopenic purpura (TTP) is rare. Only one prior patient with these two syndromes has been reported in the literature. In that case, splenectomy and proctectomy were performed to control the symptoms of TTP. We present two
Cyclic thrombocytopenia (CT) is a rare disorder with cyclic changes of the platelet counts. Though the pathogenesis of this disorder has not been clarified, recent reports suggest that periodic destruction and/or ineffective production of platelets may be important causes of the disease. We report a
## Abstract Thrombotic thrombocytopenic purpura (TTP) is a life‐threatening disease treated successfully with plasma exchange. Jehovah's Witnesses whose religious beliefs preclude them from accepting plasma exchange may require alternative forms of therapy. We report a case of one such patient who